Abstract
To examine volumetric MRI correlates of longitudinal cognitive decline in normal aging, AD, and subcortical cerebrovascular brain injury (SCVBI). Previous cross-sectional studies examining the relationship between cognitive impairment and dementia have shown that hippocampal and cortical gray matter atrophy are the most important predictors of cognitive impairment, even in cases with SCVBI. The authors hypothesized that hippocampal and cortical gray matter volume also would best predict rate of cognitive decline in cases with and without SCVBI. Subjects were recruited for a multicenter study of contributions to dementia of AD and SCVBI. The sample (n = 120) included cognitively normal, cognitively impaired, and demented cases with and without lacunes identified by MRI. Cases with cortical strokes were excluded. Average length of follow-up was 3.0 years. Measures of hippocampal volume, volume of cortical gray matter, presence of subcortical lacunes, and volume of white matter hyperintensity were derived from MRI. Random effects modeling of longitudinal data was used to assess effects of baseline MRI variables on longitudinal change in a measure of global cognitive ability. Cortical gray matter atrophy predicted cognitive decline regardless of whether lacunes were present. Hippocampal atrophy predicted decline only in those without lacunes. Neither lacunes nor white matter hyperintensity independently predicted decline. Results suggest that cortical atrophy is an index of disease severity in both AD and subcortical cerebrovascular brain injury and consequently predicts faster progression. Hippocampal volume may index disease severity and predict progression in AD. The absence of this effect in cases with lacunes suggests that this group is etiologically heterogeneous and is not composed simply of cases of AD with incidental stroke.
MeSH Terms
Aged
Aged, 80 and over
Alzheimer Disease/pathology,psychology
Cerebral Cortex/pathology
Cerebrovascular Disorders/pathology,psychology
Cognition Disorders/pathology,psychology
Female
Follow-Up Studies
Forecasting
Hippocampus/pathology
Humans
Longitudinal Studies
Magnetic Resonance Imaging/statistics & numerical data
Male
Middle Aged
Neuropsychological Tests/statistics & numerical data
Regression Analysis
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Mungas D
Department of Neurology, School of Medicine, University of California, Davis, USA. dmmungas@ucdavis.edu
Reed B R
Jagust W J
DeCarli C
Mack W J
Kramer J H
Weiner M W
Schuff N
Chui H C
References (24)
24 references, click to expand
-
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
Neurology. 1999 Apr 22;52(7):1397-403
PMID: 10227624
-
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.
J Neurol. 1999 Jun;246(6):477-85
PMID: 10431775
-
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
Neurology. 2000 Dec 12;55(11):1626-35
PMID: 11113215
-
The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease.
Arch Neurol. 2001 Aug;58(8):1243-7
PMID: 11493164
-
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
Neurology. 2001 Dec 26;57(12):2229-35
PMID: 11756602
-
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.
Neurology. 1992 Mar;42(3 Pt 1):473-80
PMID: 1549205
-
Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairments.
Addict Biol. 1998 Jul;3(3):261-70
PMID: 26734920
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
Neurology. 1989 Sep;39(9):1159-65
PMID: 2771064
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology. 1984 Jul;34(7):939-44
PMID: 6610841
-
A new clinical scale for the staging of dementia.
Br J Psychiatry. 1982 Jun;140:566-72
PMID: 7104545
-
Random-effects models for longitudinal data.
Biometrics. 1982 Dec;38(4):963-74
PMID: 7168798
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
Neurology. 1994 Apr;44(4):609-14
PMID: 8164812
-
The Clinical Dementia Rating (CDR): current version and scoring rules.
Neurology. 1993 Nov;43(11):2412-4
PMID: 8232972
-
Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation.
Psychiatr Q. 1993 Winter;64(4):371-87
PMID: 8234547
-
Staging of Alzheimer-related cortical destruction.
Eur Neurol. 1993;33(6):403-8
PMID: 8307060
-
Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia.
J Am Geriatr Soc. 1993 Jan;41(1):31-7
PMID: 8418119
-
Hippocampal MR imaging morphometry by means of general pattern matching.
Radiology. 1996 Jun;199(3):787-91
PMID: 8638006
-
Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
Age Ageing. 1996 May;25(3):209-13
PMID: 8670554
-
Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas.
Radiology. 1997 Feb;202(2):504-10
PMID: 9015081
-
The effects of additional pathology on the cognitive deficit in Alzheimer disease.
J Neuropathol Exp Neurol. 1997 Feb;56(2):165-70
PMID: 9034370
-
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
JAMA. 1997 Mar 12;277(10):813-7
PMID: 9052711
-
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
Neurology. 1997 Sep;49(3):786-94
PMID: 9305341
-
Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
J Am Geriatr Soc. 1998 Apr;46(4):444-52
PMID: 9560066
-
MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.
Neurobiol Aging. 1998 Jan-Feb;19(1):23-31
PMID: 9562499